Notice of Pre-application Webinar for Small-Cell Lung Cancer (SCLC) Consortium Covered by PAR-16-049, PAR-16-050 and PAR-16-051

Notice Number: NOT-CA-16-015

Key Dates
Release Date: December 17, 2015

Related Announcements
PAR-16-049
PAR-16-050
PAR-16-051

Issued by
National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a public pre-application webinar on January 22, 2015 at 2:00 pm (EST) for three related Funding Opportunity Announcements (FOAs):

1) PAR-16-049 entitled “Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01)”;
2) PAR-16-050 entitled “Small Cell Lung Cancer (SCLC) Consortium: Coordinating Center (U24)”; and
3) PAR-16-051, entitled “Small-Cell Lung Cancer (SCLC) Consortium: Innovative Approaches to the Prevention and Early Detection of Small Cell Lung Cancer (U01)”.

NCI staff members involved in these FOAs will provide orientation and technical assistance to potential applicants by explaining the goals and objectives of the initiative and answering questions from attendees about these FOAs, including various requirements for the U24 Coordinating Center to be proposed.

Potential applicants are encouraged to submit their questions to [email protected] in advance of the teleconference.

To join the webinar, follow the link below:

Join WebEx meeting
Meeting number: 629 426 337 
Meeting password: SCLC 

Join by phone 
1-877-668-4493 Call-in toll-free number (US/Canada) 
1-650-479-3208 Call-in toll number (US/Canada) 
Access code: 629 426 337 
Toll-free calling restrictions  

Can't join the meeting? Contact support.

Non-U.S. based investigators who will be joining the webinar by calling from abroad:
Please contact Dr. Ujhazy at [email protected] for toll-free phone number applicable to your specific country.

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to PAR-16-049, PAR-16-050, and/or PAR-16-051.

Inquiries

Please direct all inquiries to:

Peter Ujhazy
National Cancer Institute (NCI)
Telephone: 240-276-5681
Email: [email protected]